Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer.
Cancer Cell. 2019 Mar 18;35(3):401-413.e6. doi: 10.1016/j.ccell.2019.01.008. Epub 2019 Feb 14.
Cancer Cell. 2019.
PMID: 30773341
Free PMC article.
Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer.
Cato L, Neeb A, Sharp A, Buzón V, Ficarro SB, Yang L, Muhle-Goll C, Kuznik NC, Riisnaes R, Nava Rodrigues D, Armant O, Gourain V, Adelmant G, Ntim EA, Westerling T, Dolling D, Rescigno P, Figueiredo I, Fauser F, Wu J, Rottenberg JT, Shatkina L, Ester C, Luy B, Puchta H, Troppmair J, Jung N, Bräse S, Strähle U, Marto JA, Nienhaus GU, Al-Lazikani B, Salvatella X, de Bono JS, Cato AC, Brown M.
Cato L, et al. Among authors: kuznik nc.
Elife. 2017 Aug 10;6:e27159. doi: 10.7554/eLife.27159.
Elife. 2017.
PMID: 28826504
Free PMC article.
Item in Clipboard
BAG1L: a promising therapeutic target for androgen receptor-dependent prostate cancer.
Lee II, Kuznik NC, Rottenberg JT, Brown M, Cato ACB.
Lee II, et al. Among authors: kuznik nc.
J Mol Endocrinol. 2019 May;62(4):R289-R299. doi: 10.1530/JME-19-0034.
J Mol Endocrinol. 2019.
PMID: 30913537
Review.
Item in Clipboard
Development of a Benzothiazole Scaffold-Based Androgen Receptor N-Terminal Inhibitor for Treating Androgen-Responsive Prostate Cancer.
Kuznik NC, Solozobova V, Jung N, Gräßle S, Lei Q, Lewandowski EM, Munuganti R, Zoubeidi A, Chen Y, Bräse S, Cato ACB.
Kuznik NC, et al.
ACS Chem Biol. 2021 Nov 19;16(11):2103-2108. doi: 10.1021/acschembio.1c00390. Epub 2021 Sep 10.
ACS Chem Biol. 2021.
PMID: 34506104
Item in Clipboard
A chemical probe for BAG1 targets androgen receptor-positive prostate cancer through oxidative stress signaling pathway.
Kuznik NC, Solozobova V, Lee II, Jung N, Yang L, Nienhaus K, Ntim EA, Rottenberg JT, Muhle-Goll C, Kumar AR, Peravali R, Gräßle S, Gourain V, Deville C, Cato L, Neeb A, Dilger M, Cramer von Clausbruch CA, Weiss C, Kieffer B, Nienhaus GU, Brown M, Bräse S, Cato ACB.
Kuznik NC, et al.
iScience. 2022 Mar 31;25(5):104175. doi: 10.1016/j.isci.2022.104175. eCollection 2022 May 20.
iScience. 2022.
PMID: 35479411
Free PMC article.
Item in Clipboard
Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer Therapy.
Pan M, Solozobova V, Kuznik NC, Jung N, Gräßle S, Gourain V, Heneka YM, Cramer von Clausbruch CA, Fuhr O, Munuganti RSN, Maddalo D, Blattner C, Neeb A, Sharp A, Cato L, Weiss C, Jeselsohn RM, Orian-Rousseau V, Bräse S, Cato ACB.
Pan M, et al. Among authors: kuznik nc.
Cancer Res Commun. 2023 Jul 27;3(7):1378-1396. doi: 10.1158/2767-9764.CRC-23-0111. eCollection 2023 Jul.
Cancer Res Commun. 2023.
PMID: 37520743
Free PMC article.
Item in Clipboard
Cite
Cite